Organogenesis Holdings (ORGO) Gross Margin (2017 - 2026)

Organogenesis Holdings' Gross Margin history runs 10 years deep, the most recent figure standing at 30.77% for Q1 2026.

• On a quarterly basis, Gross Margin fell 4186.0% year-over-year to 30.77% in Q1 2026; TTM through Mar 2026 was 72.88%, a 297.0% decrease from a year earlier, with the FY2025 full-year figure at 75.62%, down 37.0% from the prior year.
• Gross Margin slipped to 30.77% in Q1 2026 per ORGO's latest filing, from 77.87% in the prior quarter.
• Across five years, Gross Margin topped out at 78.05% in Q2 2022 and bottomed at 30.77% in Q1 2026.
• The 5-year median for Gross Margin is 75.97% (2025), against an average of 73.01%.
• Across the five-year window, Gross Margin soared 335 bps in 2024 and sank 4186 bps in 2026, its largest moves.
• Year by year, Gross Margin stood at 76.53% in 2022, then declined by 6 bps to 72.13% in 2023, then climbed by 5 bps to 75.48% in 2024, then climbed by 3 bps to 77.87% in 2025, then slumped by 60 bps to 30.77% in 2026.
• Per Business Quant, the three latest ORGO Gross Margin figures stand at 30.77% (Q1 2026), 77.87% (Q4 2025), and 75.97% (Q3 2025).